| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 11/24/2004 | CN1548547A Enzyme analysis reagent and its prepn |
| 11/24/2004 | CN1548546A Continuous unicellular inclusion analyzing method based on microflow control chip platform |
| 11/24/2004 | CN1548545A Public primer for multiple target sequence PCR detection and its multiple target nucleic acid sequence PCR proliferation method |
| 11/24/2004 | CN1548544A PCR method adopting high-concentration glycerine and its reaction liquid and application |
| 11/24/2004 | CN1548543A PCR method with unique primer and its application |
| 11/24/2004 | CN1548535A Method of establishing mouse genome mutant embryonic stem cell library |
| 11/24/2004 | CN1548529A Separation method of buffering stem cell in human placenta |
| 11/24/2004 | CN1548456A Specific liver gene and protein related to liver carcinoma differentiation and progression |
| 11/24/2004 | CN1177062C Chinese-medicine Fritillaria-thunbergii ploymerase chain reaction appraising trigger and appraising method |
| 11/24/2004 | CN1177061C Quick-constructing method of mussel genetic fingerprinting |
| 11/24/2004 | CN1177060C Kit for detecting apoptosis |
| 11/24/2004 | CN1177059C Prediction of inflammatory disease associated with IL-1 genelocl polymorphisms |
| 11/23/2004 | US6822137 Nucleotide sequence encoding the enzyme I-SCEI and the uses thereof |
| 11/23/2004 | US6822086 Drug-carrier complexes and methods of use thereof |
| 11/23/2004 | US6822083 TSA305 gene |
| 11/23/2004 | US6822072 For diagnostics/forensics/gene therapy/chromosome mapping; expression vector design/secretion |
| 11/23/2004 | US6821945 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| 11/23/2004 | US6821789 Method and device for collecting and stabilizing a biological sample |
| 11/23/2004 | US6821770 Polynucleotide matrix-based method of identifying microorganisms |
| 11/23/2004 | US6821758 Method for the production of biopolymers with modified properties |
| 11/23/2004 | US6821754 Staphylococcus aureus genes and polypeptides |
| 11/23/2004 | US6821753 Replication incompetent herpes viruses for use in gene therapy |
| 11/23/2004 | US6821748 Determination of cytotoxic substances in whole effluent samples |
| 11/23/2004 | US6821747 Suppression of non-biological motion |
| 11/23/2004 | US6821746 Methods of screening for FabK antagonists and agonists |
| 11/23/2004 | US6821745 Regulation of human pyroglutamyl peptidase-like enzyme |
| 11/23/2004 | US6821744 Method, assay, and kit for quantifying HIV protease inhibitors |
| 11/23/2004 | US6821742 Conformational and topological protein regulation |
| 11/23/2004 | US6821741 Cells for detection of enteroviruses |
| 11/23/2004 | US6821739 Methods of diagnosing and treating Crohn's disease using Pseudomonas antigens |
| 11/23/2004 | US6821737 Detection of modulator of gene expression; obtain genetically engineered cells, incubate with modulator, monitor adjustment in gene expression, adjustment in gene expression indicates presence of modulator |
| 11/23/2004 | US6821735 Protein involved in abscisic acid signalling |
| 11/23/2004 | US6821734 Detecting restriction fragment length polymorphisms with chemiluminescent probes |
| 11/23/2004 | US6821733 Nucleic acids are contacted under conditions in which they are capable of forming stable four-way complex if nucleic acids differ in sequence; presence of complex determined with detection molecule and labeled four-stranded tracer molecule |
| 11/23/2004 | US6821731 Expression analysis of FKBP nucleic acids and polypeptides useful in the diagnosis of prostate cancer |
| 11/23/2004 | US6821730 Carbon nanotube molecular labels |
| 11/23/2004 | US6821729 Electronic apparatus for monitoring electrical impulse from biological samples |
| 11/23/2004 | US6821728 Screening system |
| 11/23/2004 | US6821727 Used for genetic replication/polymerase chain reaction (pcr); solid phase synthesis |
| 11/23/2004 | US6821726 Method for quantitatively analyzing tumor cells in a body fluid and test kits suited therefor |
| 11/23/2004 | US6821725 Methods for the diagnosis and treatment of breast cancer |
| 11/23/2004 | US6821724 Methods of genetic analysis using nucleic acid arrays |
| 11/23/2004 | US6821722 Comprises a container fitted with leak proof opening/closing system and dissolving buffer; shaking to distribute chromophore; coloration; solid phase synthesis |
| 11/23/2004 | US6821692 Kind of thin films for microsystem technology and microstructuring and their use |
| 11/23/2004 | US6821518 Polypeptides encoded by nucleotide sequences preferentially expressed in lung tumor may be used in vaccines and pharmaceutical compositions for treatment and diagnosis of lung cancer |
| 11/23/2004 | US6821483 Reagent strip for use in detection and monitoring glucose in erythrocytes |
| 11/23/2004 | US6821410 Biosensor and method of substrate quantification |
| 11/23/2004 | US6821406 Method for surface treatment of gold-plated body and surface-treated product, and process for producing gold-plated body and gold-plated body, and method for immobilization of sulfur-containing molecules |
| 11/23/2004 | US6821402 Spectral calibration of fluorescent polynucleotide separation apparatus |
| 11/23/2004 | US6821400 Electrochemical sensor with increased reproducibility |
| 11/23/2004 | CA2447762A1 Method for detecting negatively supercoiled dna |
| 11/23/2004 | CA2165663C Diagnostic reagent stabilizer |
| 11/23/2004 | CA2084076C Family of map2 protein kinases |
| 11/23/2004 | CA2012482C Hepatitis c diagnostics and vaccines |
| 11/23/2004 | CA1341466C Method for determining tissue of origin and presence and extent of cellular abnormalities |
| 11/22/2004 | CA2441681A1 Cancer monitoring and therapeutics |
| 11/21/2004 | CA2467610A1 Method for the detection of nucleic acids |
| 11/18/2004 | WO2004100229A2 Biocompatible sensor electrode assembly and method for the production thereof |
| 11/18/2004 | WO2004099782A2 Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor gpr39 (gpr39) |
| 11/18/2004 | WO2004099779A1 Diagnostics and therapeutics for diseases associated with human transmembrane serine protease 3 (tmprss3) |
| 11/18/2004 | WO2004099770A1 Method for identifying modulators of clk-1 and ubif activity |
| 11/18/2004 | WO2004099767A2 Biomolecular switching device using a holliday junction dna |
| 11/18/2004 | WO2004099755A2 Method of electrochemical detection of somatic cell mutations |
| 11/18/2004 | WO2004099447A2 Corn event tc1507 and methods for detection thereof |
| 11/18/2004 | WO2004099446A1 Method of analyzing gene introduction site |
| 11/18/2004 | WO2004099445A1 Use of a type iii restriction enzyme to isolate identification tags comprising more than 25 nucleotides |
| 11/18/2004 | WO2004099444A2 Diagnostic methods |
| 11/18/2004 | WO2004099443A2 Method for selection of optimal microarray probes |
| 11/18/2004 | WO2004099442A2 Kcnma1 as a therapeutic target in cancer treatment |
| 11/18/2004 | WO2004099441A2 Selection and evolution of chemical libraries |
| 11/18/2004 | WO2004099440A1 Methods and compositions for detecting sars virus |
| 11/18/2004 | WO2004099439A1 Methods and compositions for optimizing multiplex pcr primers |
| 11/18/2004 | WO2004099438A1 One step oligochromatographic device and method of use |
| 11/18/2004 | WO2004099437A1 Fluorescent methods for the high-throughput quantification of tartrate-resistant acid phosphatase (trap) |
| 11/18/2004 | WO2004099434A2 Homogeneous multiplex screening assays and kits |
| 11/18/2004 | WO2004099433A2 Electrochemical method to measure dna attachment to an electrode surface in the presence of molecular oxygen |
| 11/18/2004 | WO2004099432A2 Identification of biomarkers for detecting pancreatic cancer |
| 11/18/2004 | WO2004099431A2 Nucleic acid sequence detection using multiplexed oligonucleotide pcr |
| 11/18/2004 | WO2004099430A2 Substrate in the form of a ligate carrier |
| 11/18/2004 | WO2004099417A1 Genetic sequences of plant pathogen avirulence genes and uses therefor |
| 11/18/2004 | WO2004099416A1 Dna fragment specific to cytoplasmic male sterile pepper and use thereof |
| 11/18/2004 | WO2004099411A1 A method for dissecting the rna secondary structure dependence of rna-ligand interactions |
| 11/18/2004 | WO2004099399A1 Glucose dehydrogenase and production thereof |
| 11/18/2004 | WO2004099385A2 Telomere elongation |
| 11/18/2004 | WO2004099382A2 Methods for global profiling gene regulatory element activity |
| 11/18/2004 | WO2004099380A2 Method for identifying matched groups |
| 11/18/2004 | WO2004099379A2 Use of jag2 expression in diagnosis of plasma cell disorders |
| 11/18/2004 | WO2004099376A2 Assays using amyloid precursor proteins with modified beta-secretase cleavage sites to monitor beta-secretase activity |
| 11/18/2004 | WO2004099364A2 Multicellular compositions of pluripotent human embryonic stem cells and cancer cells |
| 11/18/2004 | WO2004099307A2 Nanocylinder-modified surfaces |
| 11/18/2004 | WO2004099228A2 Variants of beta-glucosidases |
| 11/18/2004 | WO2004099131A2 Compounds having a fused, bicyclic moiety for binding to the minor groove of dsdna |
| 11/18/2004 | WO2004099107A2 Dna-based memory device and method of reading and writing same |
| 11/18/2004 | WO2004098741A2 Apparatus and method for detecting live cells with an integrated filter and growth detection device |
| 11/18/2004 | WO2004098647A2 Claudins’ underexpression as markers of tumor metastasis |
| 11/18/2004 | WO2004098634A2 Protein arginine n-methyltransferase 2 (prmt-2) |
| 11/18/2004 | WO2004098531A2 Increased transduction using abc transporter substrates and/or inhibitors |
| 11/18/2004 | WO2004098521A2 Treatment and diagnostics of cancer |
| 11/18/2004 | WO2004098509A2 Compositions for inducing immune responses |
| 11/18/2004 | WO2004098497A2 Cd4+ human papillomavirus (hpv) epitopes |